Page 153 - Si Reporter

Stock market close highlights: Sensex down 368pts, Nifty at 24,487; Financial, FMCG top drags

Stock Market Close Highlights, August 12, 2025: The BSE Sensex settled 368.49 points or 0.46 per cent lower at 80,235.59 levels, while Nifty50 ended 97.65 points or 0.4 per cent lower at 24,487.40.

Why did Titagarh Rail Systems shares rise 5% despite posting weak Q1 nos?

Titagarh Rail Systems shares advanced 5.2 per cent on Tuesday, an intra-day high at ₹818 per share on BSE, despite posting weak Q1; here's why

Man Industries shares plunge 10% as revenue drops; check Q1 breakdown here

Man Industries shares fell 10 per cent after its June quarter revenue marginally dropped; profit, however, rose 45 per cent

Bumper debut! Highway Infra lists at 67% premium, hits upper circuit

Highway Infrastructure listed at ₹117 on the BSE, with a premium of 67 per cent from the issue price of ₹70

Pfizer share price up 3% on rolling out this vaccine; key details inside

Pfizer's share price gained today after the company announced the launch of its next-generation 20-valent pneumococcal conjugate vaccine (PCV20) for adults in India.

Indian Rupee trades slightly weaker ahead of CPI; opens at 87.68/$

Indian Rupee today: The domestic currency opened 2 paise weaker at 87.68 against the dollar on Tuesday

JSW Cement IPO booked 8x; check allotment status online, GMP, listing date

JSW Cement IPO allotment status: Investors can check their status on the official websites of the NSE, BSE and Kfin Technologies

Indian Rupee gives up early gains to close flat; ends at 87.66/$

Indian Rupee today: The domestic currency closed flat at 87.66 against the dollar on Monday after opening 16 paise higher

Sensex gains 746 pts, Nifty nears 24,600; 3 reasons behind Monday's rally

Why Sensex, Nifty rallied on Monday: Renewed buying in PSU banks, record MF inflows and hopes of a positive outcome from the US-Russia meet helped revive the market mood in India.

Paytm, Eternal surge up to 6%, stocks near 52-week highs

Shares of Eternal, the parent company of food aggregator Zomato and quick-commerce firm Blinkit, were up 3% to ₹310.40, quoting close to its record high level of ₹314.40

Last day! All Time Plastics IPO closes today; subscription rises 4x, GMP 2%

All Time Plastics IPO received bids for 42.05 million equity shares against 10.54 million shares on offer as of 2:30 PM on Monday

Sai Life Sciences shares surge 11% in 2 days on strong Q1 earnings

The rally in the share price of Sai Life Sciences comes after the company swung back to report a profit of ₹60 crore in Q1FY26

Sun TV shares rally 8% as promoter legal notices withdrawn; check details

Sun TV shares rose 8 per cent after it said that legal notices issued by a family member to promoter Kalanithi Maran were withdrawn

JSW Cement IPO sees modest demand, fully booked on Day 3; GMP flat

JSW Cement IPO attracted bids for 221.4 million equity shares compared to 181.29 million shares on offer, resulting in overall subscription rate of only 1.22 times.

Yatharth hits new high, zooms 52% in 3 months; what's driving the rally?

Yatharth Hospitals said the company is set to be included as a constituent of the MSCI India Small Cap Index, effective from the upcoming index rebalancing date of August 26, 2025.

BEML shares rally 5% on securing maiden overseas contract; key details here

BEML share price rallied today after the company announced that it has secured its maiden overseas contract in the Rail and Metro segment from Malaysia.

Puravankara slips 5% after posting ₹68 crore Q1 loss; check details here

Puravankara shares logged their steepest intraday fall since June after reporting a loss of ₹68 crore in Q1FY26

Biocon shares slip 3% as Q1 results miss estimates; should you sell?

Biocon shares fell 3 per cent after it reported a 95.2 per cent decline in net profit in Q1FY26

Indigo Paints share slips 8%, nears 52-week low on disappointing Q1 results

Revenue impacted due to early monsoon which affected the roads and metro projects.

Zydus Lifesciences up 2% after USFDA nods Diltiazem Hydrochloride tablets

Zydus Lifesciences share price rose 2 per cent, logging an intra-day high at ₹955 per share on BSE after USFDA gave its approval for Diltiazem Hydrochloride Tablets.